-
1
-
-
0033066251
-
Chondrosarcoma of bone: An assessment of outcome
-
Lee FY, Mankin HJ, Fondren G, Gebhardt MC, Springfield DS, Rosenberg AE, Jennings LC. Chondrosarcoma of bone: an assessment of outcome. J Bone Joint Surg Am. 1999;81:326-38.
-
(1999)
J Bone Joint Surg Am
, vol.81
, pp. 326-338
-
-
Lee, F.Y.1
Mankin, H.J.2
Fondren, G.3
Gebhardt, M.C.4
Springfield, D.S.5
Rosenberg, A.E.6
Jennings, L.C.7
-
2
-
-
0032616268
-
Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants
-
Shreve PD, Anzai Y, Wahl RL. Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics. 1999;19:61-77.
-
(1999)
Radiographics
, vol.19
, pp. 61-77
-
-
Shreve, P.D.1
Anzai, Y.2
Wahl, R.L.3
-
3
-
-
0031955474
-
Evaluation of benign versus malignant hepatic lesions with positron emission tomography
-
Delbeke D, Martin WH, Sandler MP, Chapman WC, Wright JK Jr, Pinson CW. Evaluation of benign versus malignant hepatic lesions with positron emission tomography. Arch Surg. 1998;133:510-6.
-
(1998)
Arch Surg
, vol.133
, pp. 510-516
-
-
Delbeke, D.1
Martin, W.H.2
Sandler, M.P.3
Chapman, W.C.4
Wright Jr., J.K.5
Pinson, C.W.6
-
4
-
-
0032886668
-
Oncological applications of FDG PET imaging
-
Delbeke D. Oncological applications of FDG PET imaging. J Nucl Med. 1999;40:1706-15.
-
(1999)
J Nucl Med
, vol.40
, pp. 1706-1715
-
-
Delbeke, D.1
-
5
-
-
0032812585
-
FDG-PET in differential diagnosis and grading of chondrosarcomas
-
Aoki J, Watanabe H, Shinozaki T, Tokunaga M, Inoue T, Endo K. FDG-PET in differential diagnosis and grading of chondrosarcomas. J Comput Assist Tomogr. 1999;23:603-8.
-
(1999)
J Comput Assist Tomogr
, vol.23
, pp. 603-608
-
-
Aoki, J.1
Watanabe, H.2
Shinozaki, T.3
Tokunaga, M.4
Inoue, T.5
Endo, K.6
-
8
-
-
0030254972
-
Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation
-
Cook GJ, Fogelman I, Malsey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308-14.
-
(1996)
Semin Nucl Med
, vol.26
, pp. 308-314
-
-
Cook, G.J.1
Fogelman, I.2
Malsey, M.N.3
-
9
-
-
0029938411
-
Benign versus malignant intraosseous lesions: Discrimination by means of PET with 2-[F-18] fluoro-2-deoxy-D-glucose
-
Dehdashtl F, Slegel BA, Griffeth LK, Fusselman MJ, Trask DD, McGuire AH, McGuire DJ. Benign versus malignant intraosseous lesions: discrimination by means of PET with 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology. 1996;200:243-7.
-
(1996)
Radiology
, vol.200
, pp. 243-247
-
-
Dehdashtl, F.1
Slegel, B.A.2
Griffeth, L.K.3
Fusselman, M.J.4
Trask, D.D.5
McGuire, A.H.6
McGuire, D.J.7
-
10
-
-
0033056888
-
Fluorodeoxyglucose positron emission tomography of soft tissue tumours: Is a non-invasive determination of biological activity possible?
-
Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, Diederichs CG, Schultheiss M, Kotzerke J, Reske SN. Fluorodeoxyglucose positron emission tomography of soft tissue tumours: is a non-invasive determination of biological activity possible? Eur J Nucl Med. 1999;26:599-605.
-
(1999)
Eur J Nucl Med
, vol.26
, pp. 599-605
-
-
Schulte, M.1
Brecht-Krauss, D.2
Heymer, B.3
Guhlmann, A.4
Hartwig, E.5
Sarkar, M.R.6
Diederichs, C.G.7
Schultheiss, M.8
Kotzerke, J.9
Reske, S.N.10
-
11
-
-
0033781707
-
Grading of tumors and tumor-like lesions of bone: Evaluation by FDG PET
-
Schulte M, Brecht-Krauss D, Heymer B, Guhlmann A, Hartwig E, Sarkar MR, Diederichs CG, Von Baer A, Kotzerke J, Reske SN. Grading of tumors and tumor-like lesions of bone: evaluation by FDG PET. J Nucl Med. 2000;41:1695-701.
-
(2000)
J Nucl Med
, vol.41
, pp. 1695-1701
-
-
Schulte, M.1
Brecht-Krauss, D.2
Heymer, B.3
Guhlmann, A.4
Hartwig, E.5
Sarkar, M.R.6
Diederichs, C.G.7
Von Baer, A.8
Kotzerke, J.9
Reske, S.N.10
-
12
-
-
0035008940
-
FDG PET of primary benign and malignant bone tumors: Standardized uptake value in 52 lesions
-
Aoki J, Watanabe H, Shinozaki T, Takagishi K, Ishijima H, Oya N, Sato N, Inoue T, Endo K. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology. 2001;219:774-7.
-
(2001)
Radiology
, vol.219
, pp. 774-777
-
-
Aoki, J.1
Watanabe, H.2
Shinozaki, T.3
Takagishi, K.4
Ishijima, H.5
Oya, N.6
Sato, N.7
Inoue, T.8
Endo, K.9
-
13
-
-
0034049414
-
(F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma
-
Folpe AL, Lyles RH, Sprouse JT, Conrad EU 3rd, Eary JF. (F-18) fluorodeoxyglucose positron emission tomography as a predictor of pathologic grade and other prognostic variables in bone and soft tissue sarcoma. Clin Cancer Res. 2000;6:1279-87.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 1279-1287
-
-
Folpe, A.L.1
Lyles, R.H.2
Sprouse, J.T.3
Conrad III, E.U.4
Eary, J.F.5
-
14
-
-
0036305306
-
Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies
-
D'Amico TA, Wong TZ, Harpole DH, Brown SD, Coleman RE. Impact of computed tomography-positron emission tomography fusion in staging patients with thoracic malignancies. Ann Thorac Surg. 2002;74:160-3.
-
(2002)
Ann Thorac Surg
, vol.74
, pp. 160-163
-
-
D'Amico, T.A.1
Wong, T.Z.2
Harpole, D.H.3
Brown, S.D.4
Coleman, R.E.5
-
16
-
-
0345103356
-
The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model
-
Chung JK, Chang YS, Lee YJ, Kim YJ, Jeong JM, Lee DS, Jang JJ, Lee MC. The effect of tumor size on F-18-labeled fluorodeoxyglucose and fluoroerythronitroimidazole uptake in a murine sarcoma model. Ann Nucl Med. 1999;13:303-8.
-
(1999)
Ann Nucl Med
, vol.13
, pp. 303-308
-
-
Chung, J.K.1
Chang, Y.S.2
Lee, Y.J.3
Kim, Y.J.4
Jeong, J.M.5
Lee, D.S.6
Jang, J.J.7
Lee, M.C.8
-
17
-
-
0036434696
-
The value of positron emission tomography (PET) imaging in disease staging and therapy assessment
-
Jerusalem G, Hustinx R, Beguin Y, Fillet G. The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Ann Oncol. 2002;13 (Suppl 4):227-34.
-
(2002)
Ann Oncol
, vol.13
, Issue.4 SUPPL.
, pp. 227-234
-
-
Jerusalem, G.1
Hustinx, R.2
Beguin, Y.3
Fillet, G.4
-
18
-
-
0031863737
-
Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma
-
Higashi K, Ueda Y, Seki H, Yuasa K, Oguchi M, Noguchi T, Taniguchi M, Tonami H, Okimura T, Yamamoto I. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinoma. J Nucl Med. 1998;39:1016-20.
-
(1998)
J Nucl Med
, vol.39
, pp. 1016-1020
-
-
Higashi, K.1
Ueda, Y.2
Seki, H.3
Yuasa, K.4
Oguchi, M.5
Noguchi, T.6
Taniguchi, M.7
Tonami, H.8
Okimura, T.9
Yamamoto, I.10
-
19
-
-
0027254131
-
Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose
-
Rege SD, Hoh CK, Glaspy JA, Aberle DR, Dahlbom M, Razavi MK, Phelps ME, Hawkins RA. Imaging of pulmonary mass lesions with whole-body positron emission tomography and fluorodeoxyglucose. Cancer. 1993;72:82-90.
-
(1993)
Cancer
, vol.72
, pp. 82-90
-
-
Rege, S.D.1
Hoh, C.K.2
Glaspy, J.A.3
Aberle, D.R.4
Dahlbom, M.5
Razavi, M.K.6
Phelps, M.E.7
Hawkins, R.A.8
-
20
-
-
0034948354
-
Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL)
-
Jerusalem G, Beguin Y, Najjar F, Hustinx R, Fassotte MF, Rigo P, Fillet G. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Ann Oncol. 2001;12:825-30.
-
(2001)
Ann Oncol
, vol.12
, pp. 825-830
-
-
Jerusalem, G.1
Beguin, Y.2
Najjar, F.3
Hustinx, R.4
Fassotte, M.F.5
Rigo, P.6
Fillet, G.7
-
21
-
-
0029888387
-
Metastatic prostate cancer: Initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose
-
Shreve PD, Grossman HB, Gross MD, Wahl RL. Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology. 1996;199:751-6.
-
(1996)
Radiology
, vol.199
, pp. 751-756
-
-
Shreve, P.D.1
Grossman, H.B.2
Gross, M.D.3
Wahl, R.L.4
-
22
-
-
0030254972
-
Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: Potential for error in interpretation
-
Cook GJ, Fogelman I, Malsey MN. Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation. Semin Nucl Med. 1996;26:308-14.
-
(1996)
Semin Nucl Med
, vol.26
, pp. 308-314
-
-
Cook, G.J.1
Fogelman, I.2
Malsey, M.N.3
-
23
-
-
0032921197
-
PET in lung cancer
-
Coleman RE. PET in lung cancer. J Nucl Med. 1999;40:814-20.
-
(1999)
J Nucl Med
, vol.40
, pp. 814-820
-
-
Coleman, R.E.1
|